Rahul Ray, PhD
Professor
Boston University School of Medicine
Dept of Medicine
Endocrinology, Diabetes & Nutrition

PhD, Washington State University
MSc, University of Calcutta



Expertise includes: Nanomedicine; Cancer drug therapeutics; Targeted drug delivery.

Mentor for Graduate Medical Students
Boston University School of Medicine, Division of Graduate Medical Sciences


Research Professor
Boston University School of Medicine
Physiology & Biophysics


Boston Medical Center




Structure-Function Studies of Vitamin D-Binding Protein
05/01/1997 - 04/30/2002 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK44337 07




Yr Title Project-Sub Proj Pubs
2009 Novel vitamin D analog for kidney cancer 5R21CA127629-02 4
2008 Novel vitamin D analog for kidney cancer 1R21CA127629-01A2 4
2000 STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN 5R01DK044337-07 23
1999 MOLECULAR PROBING OF VITAMIN D RECEPTOR 3R01DK047418-04S3 20
1999 STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN 5R01DK044337-06 23
1998 MOLECULAR PROBING OF VITAMIN D RECEPTOR 3R01DK047418-04S2 20
1998 STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN 5R01DK044337-05 23
1997 MOLECULAR PROBING OF VITAMIN D RECEPTOR 5R01DK047418-04 20
1997 MOLECULAR PROBING OF VITAMIN D RECEPTOR 3R01DK047418-04S1 20
1997 STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN 2R01DK044337-04A2 23
Showing 10 of 22 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Gari HH, DeGala GD, Ray R, Lucia MS, Lambert JR. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion. Cancer Lett. 2016 Oct 01; 380(2):505-12. PMID: 27452906; DOI: 10.1016/j.canlet.2016.07.017;.
  2. Gari HH, Gearheart CM, Fosmire S, DeGala GD, Fan Z, Torkko KC, Edgerton SM, Lucia MS, Ray R, Thor AD, Porter CC, Lambert JR. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers. Oncotarget. 2016 Mar 29; 7(13):15757-71. PMID: 26909599; PMCID: PMC4941275; DOI: 10.18632/oncotarget.7462;.
  3. Datta-Mitra A, Mitra A, Ray R, Raychaudhuri SP, Kundu-Raychaudhuri S. 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade. Int Immunopharmacol. 2013 Nov; 17(3):744-51. PMID: 24036370; DOI: 10.1016/j.intimp.2013.08.009;.
  4. Datta Mitra A, Raychaudhuri SP, Abria CJ, Mitra A, Wright R, Ray R, Kundu-Raychaudhuri S. 1a,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol. 2013 Jun; 133(6):1556-64. PMID: 23314787; DOI: 10.1038/jid.2013.3;.
  5. Ray R, Banks M, Abuzahra H, Eddy VJ, Persons KS, Lucia MS, Lambert JR, Holick MF. Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model. Anticancer Res. 2012 Mar; 32(3):727-31.View Related Profiles. PMID: 22399584.
  6. Sadler S, Persons KS, Jones GB, Ray R. Internalization of a C17a-alkynylestradiol-porphyrin conjugate into estrogen receptor positive MCF-7 breast cancer cells. Bioorg Med Chem Lett. 2011 Aug 1; 21(15):4638-41. PMID: 21704522; DOI: 10.1016/j.bmcl.2011.05.094;.
  7. Ray R, Lambert JR. 1a,25-Dihydroxyvitamin D3-3ß-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action. Bioorg Med Chem Lett. 2011 Apr 15; 21(8):2537-40. PMID: 21392983; PMCID: PMC3073821; DOI: 10.1016/j.bmcl.2011.02.025;.
  8. Lambert JR, Eddy VJ, Young CD, Persons KS, Sarkar S, Kelly JA, Genova E, Lucia MS, Faller DV, Ray R. A vitamin D receptor-alkylating derivative of 1a,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth. Cancer Prev Res (Phila). 2010 Dec; 3(12):1596-607.View Related Profiles. PMID: 21149334; PMCID: PMC3059596; DOI: 10.1158/1940-6207.CAPR-10-0122;.
  9. Persons KS, Eddy VJ, Chadid S, Deoliveira R, Saha AK, Ray R. Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells. Anticancer Res. 2010 Jun; 30(6):1875-80.View Related Profiles. PMID: 20651329.
  10. Kaya T, Swamy N, Persons KS, Ray S, Mohr SC, Ray R. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications. Bioorg Chem. 2009 Apr; 37(2):57-63. PMID: 19223058; PMCID: PMC2696187; DOI: 10.1016/j.bioorg.2009.01.001;.
Showing 10 of 50 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 50 publications over 23 distinct years, with a maximum of 5 publications in 1995

YearPublications
19881
19912
19921
19931
19955
19963
19974
19981
19994
20003
20011
20024
20034
20041
20062
20072
20081
20091
20102
20112
20121
20132
20162
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Grant writing
Translational research
Contact for Mentoring:


85 E. Newton St Fuller Building
Boston MA 02118
Google Map


Ray's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department